Cargando…

Clinical Utility of Pegaspargase in Children, Adolescents and Young Adult Patients with Acute Lymphoblastic Leukemia: A Review

Acute lymphoblastic leukemia (ALL) is a heterogenous hematological malignancy representing 25% of all cancers in children less than 15 years of age. Significant improvements in survival and cure rates have been made over the past four decades in pediatric ALL treatment. Asparaginases, derived from E...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bender, Cynthia, Maese, Luke, Carter-Febres, Maria, Verma, Anupam
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8064615/ https://www.ncbi.nlm.nih.gov/pubmed/33907490 http://dx.doi.org/10.2147/BLCTT.S245210

Ejemplares similares

Levocarnitine for pegaspargase‐induced hepatotoxicity in older children and young adults with acute lymphoblastic leukemia
por: Schulte, Rachael, et al.
Publicado: (2021)

Perforated jejunitis in a child with acute lymphoblastic leukemia treated with pegaspargase
por: Tang, Elizabeth R., et al.
Publicado: (2018)

Current Use of Asparaginase in Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma
por: Maese, Luke, et al.
Publicado: (2022)

Pegaspargase: A Review in Acute Lymphoblastic Leukaemia
por: Heo, Young-A., et al.
Publicado: (2019)

Treatment of Children with Advanced-Stage Lymphoblastic Lymphoma with Pegaspargase
por: Yu-tong, Zhang, et al.
Publicado: (2014)

Correction to: Pegaspargase: A Review in Acute Lymphoblastic Leukaemia
por: Heo, Young-A., et al.
Publicado: (2019)

Pegaspargase-modified risk-oriented program for adult acute lymphoblastic leukemia: results of the GIMEMA LAL1913 trial
por: Bassan, Renato, et al.
Publicado: (2023)

Randomized, Parallel Group, Open-Label Bioequivalence Trial of Intramuscular Pegaspargase in Patients With Relapsed Acute Lymphoblastic Leukemia
por: Nookala Krishnamurthy, Manjunath, et al.
Publicado: (2020)

P386: COMPARISON OF THE PHARMACOKINETICS OF THE LIQUID AND THE LYOPHILIZED FORMULATIONS OF PEGASPARGASE IN THE TREATMENT OF PEDIATRIC PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA (ALL)
por: Karachunskiy, Alexander, et al.
Publicado: (2023)

Salvage treatment in IDH1 mutated acute lymphoblastic leukemia with venetoclax plus methotrexate and pegaspargase: A case report
por: Li, Dan, et al.
Publicado: (2023)

Treatment of Adolescent and Young Adults with Acute Lymphoblastic Leukemia
por: Ribera, Josep-Maria, et al.
Publicado: (2014)

Development of a Lyophilized Formulation of Pegaspargase and Comparability Versus Liquid Pegaspargase
por: Faschinger, Alexander M., et al.
Publicado: (2019)

COVID-19 Vaccination Outcomes in Children, Adolescents, and Young Adults with Acute Lymphoblastic Leukemia
por: Parker, Rebecca S, et al.
Publicado: (2022)

The cost-effectiveness of pegaspargase versus native asparaginase for first-line treatment of acute lymphoblastic leukaemia: a UK-based cost-utility analysis
por: Hu, Xingdi, et al.
Publicado: (2019)

Venetoclax for Children and Adolescents with Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma
por: Gibson, Amber, et al.
Publicado: (2021)

Late Effects in Survivors of Adolescent and Young Adult Acute Lymphoblastic Leukemia
por: Muffly, Lori, et al.
Publicado: (2020)

Outcomes of Philadelphia Positive Acute Lymphoblastic Leukemia in Adolescent and Young Adults
por: Ahmed, Umair, et al.
Publicado: (2022)

Health utility of children with acute lymphoblastic leukemia in China
por: Wang, Wei, et al.
Publicado: (2023)

Optimal therapy for adolescents and young adults with acute lymphoblastic leukemia-current perspectives
por: Lee, Jae Wook
Publicado: (2020)

Practical guidance for the management of acute lymphoblastic leukemia in the adolescent and young adult population
por: Carobolante, Francesca, et al.
Publicado: (2020)

Clinical Characteristics and Outcomes of Acute Lymphoblastic Leukemia in Adolescents and Young Adults in Malawi
por: Kasonkanji, Edwards, et al.
Publicado: (2022)

Improved survival of adolescents and young adults patients with T-cell acute lymphoblastic leukemia
por: Hanbali, Amr, et al.
Publicado: (2023)

The Evolution of Chimeric Antigen Receptor T-Cell Therapy in Children, Adolescents and Young Adults with Acute Lymphoblastic Leukemia
por: Ragoonanan, Dristhi, et al.
Publicado: (2022)

Methotrexate-induced Transient Encephalopathy in an Adolescent and Young Adult Patient with Acute Lymphoblastic Leukemia
por: Teshima, Kazuaki, et al.
Publicado: (2021)

Disparities in trial enrollment and outcomes of Hispanic adolescent and young adult acute lymphoblastic leukemia
por: Muffly, Lori, et al.
Publicado: (2022)

Outcome of adolescents and young adults with acute lymphoblastic leukemia in a single center in Brazil
por: Aguiar, Thais Ferraz, et al.
Publicado: (2023)

Pediatric-inspired chemotherapy incorporating pegaspargase is safe and results in high rates of minimal residual disease negativity in adults up to the age of 60 years with Philadelphia chromosome-negative acute lymphoblastic leukemia
por: Geyer, Mark B., et al.
Publicado: (2020)

Adherence to 6-Mercaptopurine in children and adolescents with Acute Lymphoblastic Leukemia
por: Alsous, Mervat, et al.
Publicado: (2017)

Best Practices in Adolescent and Young Adult Patients with Acute Lymphoblastic Leukemia: A Focus on Asparaginase
por: Boissel, Nicolas, et al.
Publicado: (2015)

Incidence of venous thrombosis after peg-asparaginase in adolescent and young adults with acute lymphoblastic leukemia
por: Underwood, Brynne, et al.
Publicado: (2020)

A modified CALGB 10403 in adolescents and young adults with acute lymphoblastic leukemia in Central America
por: Rangel-Patiño, Juan, et al.
Publicado: (2023)

Acute lymphoblastic leukemia in children and adolescents: prognostic factors and analysis of survival
por: Lustosa de Sousa, Daniel Willian, et al.
Publicado: (2015)

Prevalence of Osteopathologies in Children and Adolescents After Diagnosis of Acute Lymphoblastic Leukemia
por: Schündeln, Michael M., et al.
Publicado: (2020)

L-Asparaginase Toxicity in the Treatment of Children and Adolescents with Acute Lymphoblastic Leukemia
por: Schmidt, Madalina-Petronela, et al.
Publicado: (2021)

Acute lymphoblastic leukemia presenting with limping in a young adult
por: Habib, Mhd Baraa, et al.
Publicado: (2022)

Adherence to Oral Chemotherapy in Acute Lymphoblastic Leukemia during Maintenance Therapy in Children, Adolescents, and Young Adults: A Systematic Review
por: Zeng, Xiaopei L., et al.
Publicado: (2023)

Pediatric-Inspired Regimens in the Treatment of Acute Lymphoblastic Leukemia in Adolescents and Young Adults: A Systematic Review
por: Zeckanovic, Aida, et al.
Publicado: (2023)

Pegaspargase Induced Hypertriglyceridemia Resulting in Severe Fatal Pancreatitis
por: Vyas, Neil, et al.
Publicado: (2015)

Myeloid/T-cell acute lymphoblastic leukemia in children and adults
por: Chiaretti, Sabina, et al.
Publicado: (2011)

Pooled safety analysis of tisagenlecleucel in children and young adults with B cell acute lymphoblastic leukemia
por: Levine, John E, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_oalhh911b22a3v46buj6is38fe